Bulletin
Investor Alert

Novartis AG ADR

NYS: NVS

GO
/marketstate/country/us

After Hours

NVS
/zigman2/quotes/203243705/composite

$

87.34

Change

+0.38 +0.44%

Volume

Volume 4,029

Sep 30, 2020, 5:38 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203243705/composite

Today's close

$ 87.04

$ 86.96

Change

-0.08 -0.09%

Day low

Day high

$86.48

$87.47

Open
Open: 87.29

52 week low

52 week high

$69.18

$99.84

Open

Market cap

$192.57B

Average volume

1.85M

P/E ratio

27.67

Rev. per Employee

$415,614

EPS

3.14

Dividend

3.09

Div yield

2.31%

Ex dividend date

3/3/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nvs

MarketWatch News on NVS

  1. The Pandemic Speeds Up the Health-Care Revolution

    8:56 a.m. Sept. 28, 2020

    - Lauren R. Rublin

  2. Novartis Stock Should Rise 20%, Analyst Says

    11:12 a.m. Sept. 11, 2020

    - Bill Alpert

  3. Stocks Close Mixed as Record Month Comes to a Close

    4:47 p.m. Aug. 31, 2020

    - Barbara Kollmeyer

  4. Drug maker Teva’s U.S. unit indicted on price-fixing charges

    6:42 p.m. Aug. 25, 2020

    - Brent Kendall

  5. These Companies Are Seeking a Cure for Sickle Cell

    11:52 a.m. July 25, 2020

    - Bill Alpert

  6. Tesla, AT&T, Microsoft, Intel, and Other Stocks to Watch This Week

    3:00 p.m. July 19, 2020

    - Nicholas Jasinski

  7. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nvs

Other News on NVS

  1. IPO Update: Virios Therapeutics Seeks $30 Million IPO

    5:35 p.m. Sept. 29, 2020

    - Seeking Alpha

  2. Amgen prevails in Enbrel patent dispute with Novartis

    11:55 a.m. Sept. 29, 2020

    - Seeking Alpha

  3. Blueprint Medicines Rises YTD on Robust Ayvakit Progress

    11:46 a.m. Sept. 29, 2020

    - Zacks.com

  4. AbbVie Elezanumab Gets FDA's Fast Track and Orphan Drug Tags

    10:52 a.m. Sept. 29, 2020

    - Zacks.com

  5. Here’s Why Eastman Kodak Is Going to $0

    1:17 p.m. Sept. 28, 2020

    - InvestorPlace.com

  6. Sustainable-Bond Market Boosted by Europe’s Top Institutions

    12:34 p.m. Sept. 25, 2020

    - Anna Hirtenstein

  7. FDA issues final rule for importation of drugs from abroad

    7:21 a.m. Sept. 25, 2020

    - Seeking Alpha

  8. A Bet on Europe Is a Bet on Drugs, Against Tech

    5:08 a.m. Sept. 25, 2020

    - Stephen Wilmot

  9. AC Immune's Candidate Fails in Alzheimer's Disease Study

    10:35 a.m. Sept. 24, 2020

    - Zacks.com

  10. Pfizer Seeks Xalkori's Label Expansion, Gets Priority Review

    10:22 a.m. Sept. 24, 2020

    - Zacks.com

  11. Why Pfizer Is Seriously Mispriced

    11:13 a.m. Sept. 18, 2020

    - GuruFocus.com

  12. Why Novartis’ Absence From the Covid-19 Vaccine Race Is a Benefit

    9:51 a.m. Sept. 18, 2020

    - InvestorPlace.com

  13. Taysha Gene Therapies Sets $130 Million Offering

    4:00 p.m. Sept. 17, 2020

    - GuruFocus.com

  14. Loading more headlines...
/news/pressrelease/company/us/nvs

Press Releases on NVS

  1. Therapeutics Market Anticipated To Expand At A CAGR Around 15.7% During 2019-2027

    6:35 p.m. Today

    - ABNewswire

  2. MHealth Apps Market Share, CAGR, Trends, Segmentation and Forecast 2020 to 2027

    8:45 a.m. Today

    - Profound

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.